Literature DB >> 30198129

Lifestyle and periodontitis: The emergence of personalized periodontics.

P Mark Bartold1.   

Abstract

Personalized medicine is a medical model that involves the tailoring of healthcare - with medical decisions, practices, and/or products being customized to an individual patient. In this model, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient's genetic content or other epidemiologic, sociologic, molecular, physiologic, or cellular analyses. With the advent of major advances in periodontal medicine, including genomic discoveries and greater understanding of the multifactorial nature of periodontitis, it seems that the time is ripe to use personalized medicine as a model for personalized periodontics. This volume of Periodontology 2000 explores how new advances in our understanding of periodontitis within a medical model can evolve into new treatment strategies tailor-made for individual patients and not merely based on wholesale treatment paradigms.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 30198129     DOI: 10.1111/prd.12237

Source DB:  PubMed          Journal:  Periodontol 2000        ISSN: 0906-6713            Impact factor:   7.589


  15 in total

Review 1.  The Emerging Regulatory Role of Circular RNAs in Periodontal Tissues and Cells.

Authors:  Kexin Jiao; Laurence J Walsh; Sašo Ivanovski; Pingping Han
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

2.  Periodontal Treatment Improves Serum Levels of Leptin, Adiponectin, and C-Reactive Protein in Thai Patients with Overweight or Obesity.

Authors:  Notkamon Wanichkittikul; Penpan Laohapand; Chayasin Mansa-Nguan; Supanee Thanakun
Journal:  Int J Dent       Date:  2021-02-02

Review 3.  Epigenetic regulation of inflammation in periodontitis: cellular mechanisms and therapeutic potential.

Authors:  Krzysztof T Jurdziński; Jan Potempa; Aleksander M Grabiec
Journal:  Clin Epigenetics       Date:  2020-11-30       Impact factor: 6.551

4.  Effects of gold nanoparticles combined with human β-defensin 3 on the alveolar bone loss of periodontitis in rat.

Authors:  Jing Zhou; Lingjun Li; Di Cui; Xiaoting Xie; Wenrong Yang; Fuhua Yan
Journal:  Biomed Eng Online       Date:  2021-11-24       Impact factor: 2.819

5.  Nonsurgical Periodontal Treatment Options and Their Impact on Subgingival Microbiota.

Authors:  Susanne Schulz; Jamal M Stein; Anne Schumacher; David Kupietz; Sareh S Yekta-Michael; Florian Schittenhelm; Georg Conrads; Hans-Günter Schaller; Stefan Reichert
Journal:  J Clin Med       Date:  2022-02-23       Impact factor: 4.241

6.  Displacement in root apex and changes in incisor inclination affect alveolar bone remodeling in adult bimaxillary protrusion patients: a retrospective study.

Authors:  Huimin Mao; Andi Yang; Yue Pan; Houxuan Li; Lang Lei
Journal:  Head Face Med       Date:  2020-11-20       Impact factor: 2.151

7.  Association among serum and salivary A. actinomycetemcomitans specific immunoglobulin antibodies and periodontitis.

Authors:  Gaetano Isola; Alessandro Polizzi; Romeo Patini; Sebastiano Ferlito; Angela Alibrandi; Giuseppe Palazzo
Journal:  BMC Oral Health       Date:  2020-10-15       Impact factor: 2.757

8.  Use of Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects: A Systematic Review and Meta-Analysis.

Authors:  Liang Chen; Yi Ding; Guoping Cheng; Sue Meng
Journal:  Biomed Res Int       Date:  2021-02-04       Impact factor: 3.411

Review 9.  The Effect of Acknowledged and Novel Anti-Rheumatic Therapies on Periodontal Tissues-A Narrative Review.

Authors:  Maria-Alexandra Martu; George-Alexandru Maftei; Ionut Luchian; Ovidiu Mihail Stefanescu; Mihaela Monica Scutariu; Sorina Mihaela Solomon
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-23

Review 10.  Oral Versus Gastrointestinal Mucosal Immune Niches in Homeostasis and Allostasis.

Authors:  Lina J Suárez; Silie Arboleda; Nikola Angelov; Roger M Arce
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.